BSS-17911-16426
3 vaccinations
3 coded responses
10 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 070 / NJ
- Registered
- 2021-01-27
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-12
Dose 1 — Pfizer-BioNTech
-
2021-01-12
Dose 2 — Pfizer-BioNTech
-
2021-01-27
Registered in v-safe
-
2021-01-27
Survey response — day 14, dose 1MedDRA: Haemorrhage, Skin lesion, Specialist consultation — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Eight hours after recieving the second dose, I developed small non-raised pinpoint lesions over the anterior aspect of my legs. The pinpoint lesions started to spread overnight into 5 inch by 5 inch flat, non-raised lesions that became hemorrhagic. · Healthcare visit (other): Dermatologist, in office.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-27
Report sent to call center — day 14, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2021-02-02
-
2021-02-09
Survey response — day 28, dose 2MedDRA: Injection site rash, Rash — Feeling: GoodFree text: Rash similar to the initial on legs on injection side upper arm only. Occurred around 1/30. Incorrectly submitted last weeks check in.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-16
- 2021-02-23
- 2021-04-14
- 2021-04-14
-
2021-07-15
Survey response — 6 months, dose 2MedDRA: Rash — Feeling: GoodFree text: Same time of rash on the right inner thigh.MedDRA releases: 2021-09,2024-11 · check-in free text available
- 2022-01-19
-
2022-01-31
Dose 3 — Pfizer-BioNTech
- 2022-05-04
- 2023-01-31
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-12 | Pfizer-BioNTech | |
| 2 | 2021-01-12 | Pfizer-BioNTech | |
| 3 | 2022-01-31 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 2 — day 14, dose 1
Symptoms: Eight hours after recieving the second dose, I developed small non-raised pinpoint lesions over the anterior aspect of my legs. The pinpoint lesions started to spread overnight into 5 inch by 5 inch flat, non-raised lesions that became hemorrhagic. cut off by CDC
Healthcare visit (other): Dermatologist, in office.
Release 3 — day 28, dose 2
Symptoms: Rash similar to the initial on legs on injection side upper arm only. Occurred around 1/30. Incorrectly submitted last weeks check in.
Release 9 — 6 months, dose 2
Symptoms: Same time of rash on the right inner thigh.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Specialist consultation | ✓ | ✓ | ✓ |
| SD | Haemorrhage | ✓ | ✓ | ✓ |
| SD | Injection site rash | ✓ | ✓ | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Skin lesion | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release